A 72-year-old Japanese woman presented to the emergency department with a 39℃ fever. One month earlier, she had undergone artificial knee joint replacement for gonarthrosis on her left side. Her immunity was normal. On admission, she had salmon-pink erythema with a clear borderline in only one location on her lower left leg ([Picture 1](#g001){ref-type="fig"}) without infiltration or tenderness; this indicated that the erythema was very different from common cellulitis. After hospitalization, multiple new erythema appeared discontinuously with each passing day ([Picture 2](#g002){ref-type="fig"}). Her white blood cell count was normal; however, her C-reactive protein (CRP) rose as high as 10 mg/dL. Cellulitis caused by *Helicobacter cinaedi* was suspected due to the unique characteristics of her erythema. *Helicobacter cinaedi* was isolated from blood cultures on the fifth day ([Picture 3](#g003){ref-type="fig"}). She was treated with parental antibiotics (cefazolin 1 g every 8 hours and gentamicin 200 mg every 24 hours) until the pathogen was no longer detected, and her treatment was de-escalated: ampicillin 1 g every 6 hours for 21 days after detection. At six months of follow-up she showed no relapse. The infection route was unknown.*Helicobacter cinaedi* infection has recently been reported in immunocompetent patients, especially as cellulitis ([@B1]). Cellulitis-associated *Helicobacter cinaedi* has three features; sudden-onset erythema accompanied by a high fever, mild cellulitis, and multiple erythema on the extremities ([@B2]). Five or more days is sometimes necessary for the incubation of blood cultures ([@B3]); as such, the disease is often missed. *Helicobacter cinaedi* can easily relapse, so it is important to apply long-term therapy for two to six weeks ([@B3]).
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